Send to

Choose Destination
Allergy. 2018 Jul;73(7):1369-1382. doi: 10.1111/all.13370. Epub 2017 Dec 15.

Comorbid "treatable traits" in difficult asthma: Current evidence and clinical evaluation.

Tay TR1,2, Hew M1,3.

Author information

Allergy, Asthma and Clinical Immunology, The Alfred Hospital, Melbourne, Vic., Australia.
Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore.
School of Public Health & Preventive Medicine, Monash University, Melbourne, Vic., Australia.


The care of patients with difficult-to-control asthma ("difficult asthma") is challenging and costly. Despite high-intensity asthma treatment, these patients experience poor asthma control and face the greatest risk of asthma morbidity and mortality. Poor asthma control is often driven by severe asthma biology, which has appropriately been the focus of intense research and phenotype-driven therapies. However, it is increasingly apparent that extra-pulmonary comorbidities also contribute substantially to poor asthma control and a heightened disease burden. These comorbidities have been proposed as "treatable traits" in chronic airways disease, adding impetus to their evaluation and management in difficult asthma. In this review, eight major asthma-related comorbidities are discussed: rhinitis, chronic rhinosinusitis, gastroesophageal reflux, obstructive sleep apnoea, vocal cord dysfunction, obesity, dysfunctional breathing and anxiety/depression. We describe the prevalence, impact and treatment effects of these comorbidities in the difficult asthma population, emphasizing gaps in the current literature. We examine the associations between individual comorbidities and highlight the potential for comorbidity clusters to exert combined effects on asthma outcomes. We conclude by outlining a pragmatic clinical approach to assess comorbidities in difficult asthma.


comorbidity; diagnosis; difficult asthma; severe asthma; treatment


Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center